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Protected by vitiligo
An association of polymorphisms in the tyrosinase (TYR) gene 
with vitiligo suggests that patients with this autoimmune disease 
are less susceptible to melanoma as a result of strong antityrosi-
nase immunity; however, the lack of protective melanin in these 
patients may increase their susceptibility to photodamage and 
thus their risk for melanoma and nonmelanoma skin cancer. 
In a large, retrospective cohort study, Teulings and colleagues 
detected a significantly lower lifetime probability of melanoma 
in vitiligo patients. Even following adjustment for known risk 
factors of childhood sunburn and the presence of more than 
100 nevi, this decrease remained significant. In addition, vitiligo 
patients were less likely to develop nonmelanoma skin cancer, 
and phototherapy (psoralen plus ultraviolet light A and/or nar-
rowband ultraviolet light B) did not increase the already lower 
risk of skin cancer in these patients, supporting the use of this 
effective therapy modality in vitiligo treatment. (Br J Dermatol 
168:162–71, 2013) Selected by T. Schwarz
Divergent origins
Although epithelial–mesenchymal transition (EMT) has been 
proposed to be an essential prerequisite for metastasis or pro-
motion of local invasion, human metastases derived from epi-
thelial primary tumors are often similar in morphology and 
immunophenotype to the original tumor and do not display 
mesenchymal morphology. Inflammatory agents have been 
implicated in the linear development from benign papilloma 
to squamous cell carcinoma (SCC) via the classic pathway 
(class A carcinoma). Wong and colleagues recently demon-
strated that reduced exposure to tumor-promoting TPA-induced 
chronic inflammation results not only in a decrease in classic 
papillomas and SCCs but also in the emergence of malignant 
carcinomas with EMT-like characteristics (class B carcinomas). 
These carcinomas exhibit reduced Hras and EGFR signaling. 
The investigators propose that these tumors arise from a different 
target cell that does not require reprogramming by inflamma-
tory and tumor-promoting stimuli, suggesting that divergence of 
the two pathways occurs early in carcinogenesis or via separate 
events in distinct target cells. (Genes Dev 27:670–82, 2013) 
Selected by T. Schwarz
An Rx for caution
The recent increase in allergic disease, including atopic derma-
titis or eczema, has been attributed to the so-called “hygiene 
hypothesis,” based on various socioeconomic factors that 
decrease childhood infections. Early-life exposure to antibiot-
ics has been linked to an increased risk of eczema, although 
confirmatory evidence has not been published. Tsakok and 
colleagues conducted a systematic review and meta-analysis 
of 20 cross-sectional, case–control, and cohort studies in order 
to examine the relationship between antibiotic exposure during 
the prenatal and neonatal periods and subsequent development 
of eczema. A significant positive association between early anti-
biotic prescription and eczema risk was found, and this associa-
tion was similar in cross-sectional and longitudinal studies. For 
each additional course of antibiotics during the initial year of 
life, a 7% increase in eczema risk was found. Future prospec-
tive studies and/or population-based approaches are required 
to understand this complex relationship because a causal 
relationship between antibiotics and allergic disease would 
clearly impact both the clinical and public-health sectors. (Br J 
Dermatol 169:983–91, 2013) Selected by H. Williams
The nod goes to surgery
The use of imiquimod has previously been reported as a suc-
cessful treatment strategy for basal cell carcinoma (BCC), with 
published success rates of 88% for superficial BCC and 76% 
for nodular disease; however, surgical excision is considered 
the gold-standard treatment for this common malignant dis-
ease. A paucity of studies directly comparing BCC treatment 
options led Bath-Hextall and colleagues to perform a multi-
center, parallel-group, pragmatic, noninferiority, random-
ized controlled trial involving 501 participants with the aim 
of comparing surgical excision with imiquimod 5% cream in 
BCC treatment. Based on a predefined noninferiority margin at 
three years of follow-up, imiquimod was found to be inferior to 
surgery. More tumors recurred in imiquimod-treated patients, 
and no compensatory increased cosmetic effect was reported 
by the patients. With a similar cost and greater success, 
surgical excision is the recommended option; nonetheless, 
imiquimod may be useful for individuals with low-risk BCC 
with more than one superficial lesion or for those who pre-
fer home treatment, as success rates with this cream were still 
good and recurrent lesions can be treated with surgery. (Lancet 
Oncol 15:96–105, 2014) Selected by B. Gilchrest
Source and target
To elucidate the molecular signals that regulate stems cells 
residing in the adult interfollicular epidermis (IFE), Lim and 
colleagues recently examined the presence of Wnt and Wnt 
inhibitors in the skin as possible self-renewal factors. The inves-
tigators employed mouse lineage tracing and clonal analyses to 
demonstrate that the Wnt target Axin2 marks the IFE stem cells, 
contributes to regeneration of punch wounds, and requires 
Wnt/β-catenin signaling for proliferation. Tissue stem cells are 
typically influenced by signals secreted by nearby “niche” cells. 
Here, the Axin2-expressing basal cells themselves were the 
source of the Wnt signals. Taken together, these findings indicate 
that the epidermal stem cells produce their own self-renewing 
signals and differentiating signals for their progeny and suggest 
that the presence of multiple Wnt and Wnt inhibitor molecules 
offers a mechanism for fine-tuning these stem cells. (Science 
342:1226–30, 2013) Selected by P. BergstresserJournal of Investigative Dermatology (2014) 134, 873. doi:10.1038/jid.2014.58
